Exelixis's chart data is dated 2026-10-09. Recorded technical signals: Near 52-week high, MA aligned, VCP, Bollinger breakout, MACD bullish cross. There are 9 published signal records.
Exelixis last closed at $59.86 (+1.42%) on 2026-10-09. Signals today: Near 52-week high, MA aligned, VCP, Bollinger breakout, MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is 17.8×. Its overall grade ranks 93 of 738 stocks in Healthcare.
About this company
Exelixis last closed at $59.86 (+1.42%) on 2026-10-09. Signals today: Near 52-week high, MA aligned, VCP, Bollinger breakout, MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 93/738
Valuation grade F
Related stocks
- RocheCompetitor
Exelixis와 동일한 표적 항암제·종양학 영역에서 경쟁하는 글로벌 제약사
- Bristol Myers SquibbCompetitor
종양학 파이프라인과 면역항암제 시장에서 Exelixis의 주요 경쟁사
- MerckCompetitor
암 치료제 시장에서 Exelixis와 경쟁하는 대형 제약사
ETFs holding this stock
Invesco S and P MidCap Quality ETF · Allspring SMID Core ETF · Janus Henderson Small/Mid Cap Growth Alpha ETF
Details →About Exelixis
- What technical signals does Exelixis (EXEL) have?
- Exelixis current technical signals: MA alignment (score 0.48).
- Is Exelixis a cup-and-handle pattern?
- No. Exelixis has no valid Cup signal right now.
- What published figures are available for Exelixis?
- Market cap: $16.05B. Trailing 12 months PER: 17.8×. Latest quarter PBR: 8.31×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Exelixis, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.